Use of long-chain n-alkyl derivatives of deoxynojirimycin...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/445 (2006.01) A61P 3/00 (2006.01)

Patent

CA 2352544

A novel method is disclosed for the treatment of a patient affected with Gaucher's disease or other such glycolipid storage diseases. The method comprises administering to said patient a therapeutically effective amount of a long-chain N-alkyl derivative of deoxynojirimycin to alleviate or inhibit the glycolipid storage disease. The long-chain alkyl group has from nine to about 20 carbon atoms and preferably is nonyl or decyl.

L'invention concerne un procédé de traitement de la maladie de Gaucher ou autre maladie liée au stockage des glycolipides, qui consiste à administrer une quantité thérapeutiquement efficace de dérivé N-alkyle à chaîne longue de désoxynojirimycine pour atténuer ou inhiber le stockage des glycolipides. Le groupe alkyle à chaîne longue comprend entre 9 et environ 20 atomes de carbone, et il s'agit de préférence de nonyle ou de décyle.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of long-chain n-alkyl derivatives of deoxynojirimycin... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of long-chain n-alkyl derivatives of deoxynojirimycin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of long-chain n-alkyl derivatives of deoxynojirimycin... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1702095

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.